An act of friendship toward new teammates has turned into a full-fledged philanthropic endeavor for Cincinnati Bengals player Ted Karras. Fans and local media have quickly taken notice of Karras and other players wearing new "Cincy" hats in the locker room. Starting tonight at 7 p.m. EST, the hats are being made available to the public for the first time.
"The Cincy Hat" will be sold online, with the proceeds going to the Village of Merici in Indianapolis. The organization provides direct support services, learning opportunities, and independent living through partnerships with various developers. The Village of Merici currently supports more than 75 people throughout Indianapolis with a goal of self-reliance.
"The hats were originally a fun gift for my new teammates through a family friend's golf supply business," Karras says. "I figured everyone loves to get a piece of gear, and the response from my teammates, Bengal fans, and media members was extraordinary. The demand for the hats grew rapidly thanks to my teammates wearing them in interviews, and we decided to sell them, but it had to benefit Village of Merici."
Karras' involvement with Village of Merici is thanks to childhood friend Matt Renie. Karras and Renie were high school classmates at Cathedral High School in Indianapolis.
"Ted grew up as a family friend observing his friend's brother who has intellectual and developmental disabilities," says Colleen Renie, Executive Director of Village of Merici. "Ted also has a family member with autism. He saw the potential in individuals with intellectual and developmental disabilities and their desire to live independently as they grew up."
There are currently three hats available, with a fourth in the works. The hats retail for $35 each, and customers can choose from black, orange or white. The fourth hat will be white with a black logo.
The funds will go to supporting the Village of Merici programs that teach and support individuals in independent living skills to enable them to be successful.
"I am so grateful that a fun gift and project has found a special purpose," Karras says. "It's a great hat with an awesome design that I hope can become the unofficial hat of the Bengals. The Village of Merici is a very special place that does so much good. Any way I can ever help their cause is a special opportunity for me."
To purchase a hat, visit thecincyhat.com. The website also offers a link for donations for Village of Merici. For more information regarding Village of Merici, visit villageofmerici.org or call Karyl Davis, Director of Development, at 317-601-0513.
Contact Information:
Karyl Davis
Director of Development [email protected]
317-601-0513
Incredible discounts offered on doctor-recommended TV listening systems, headsets and speakers during its weeklong Black Friday sale
SPRING VALLEY, Calif. - November 22, 2022 - (Newswire.com)
There may be no battle more contested over the holidays than the volume of a living room television.
But thanks to an innovative television listening solution and a weeklong Black Friday sale, this year's holidays may sound a bit clearer and less jarring to others in homes across the U.S. and beyond.
TV Ears® Doctor Recommended TV Listening Systems & Headsets is pleased to announce from midnight Wednesday, Nov. 23 to 11:59 p.m. Wednesday, Nov. 30, all orders are eligible for a full 35 percent off of regular price using the promo code THANKS35.
"It is gratifying to be able to offer our TV listening systems this holiday season at a record low price," said Nino Wehbe, TV Ears general manager. "Since 1998, we have been working to help millions of customers enjoy their favorite television programs, news and sports. With this offer, we look forward to helping countless more."
Featured in AARP Magazine, the easy-to-use tool has a five-year warranty and works with all hearing types, he said.
"While new technologies come out every day, they are often difficult to use and often fail to deliver the crisp and clear volume needed to positively impact television watching," Wehbe said. "Our solution is different. We specifically designed TV Ears to be a simple solution that allows anyone to enjoy watching television."
He said Bluetooth headphones and hearing aids are notoriously unreliable for this purpose and can create an unrewarding experience.
"With TV Ears, there is no complicated pairing process required to use it correctly," Wehbe said. "Unlike rivals, TV Ears products provide an enjoyable and hassle-free TV listening experience without relying on Bluetooth and its inconsistent sound quality."
TV Ears utilize proprietary Voice Clarifying Technology to create clear, real-time television audio for the wearer.
"For more than 20 years, TV Ears has assisted people in hearing television clearly without disturbing others," Wehbe said. "Using Voice Clarifying Circuitry, TV Ears manufactures and sells voice-clarifying television headphones and speakers. This proprietary audio curve makes television dialogue clearer while background noise, such as music and sound effects, is reduced."
"With TV Ears' Speed of Light Infrared Technology (SoLIT) and 'wall-breaking' 5.8 GHz technology, television audio can be distributed throughout the house to compatible headsets and speakers," he continued. "And with a max volume of 120 decibels, TV Ears is twice as loud as other systems, with no pairing required."
"For those parents, grandparents, aunts and uncles dealing with hearing loss, being able to connect with others through entertainment like music and television can mean everything," Wehbe said. "With our Black Friday deal, you can give the gift of gathering and celebration this year, and at a low cost."
For more information about TV Ears or to take advantage of the weeklong Black Friday sale, visit https://www.tvears.com.
Contact Information:
Nino Wehbe
General Manager, TV Ears, Inc. [email protected]
(888) 883-3277
Global sustainability consulting firm ADEC ESG Solutions releases suite of corporate educational material designed to guide organizations on the path to decarbonization and net-zero goals.
IRVINE, Calif. - November 22, 2022 - (Newswire.com)
ADEC ESG Solutions, an ADEC Innovations company and global leader in sustainability solutions that helps organizations responsibly grow and operate, last week hosted an online learning event focused on the process of decarbonization. The event's goal was to educate participating organizations on decarbonization and outline a foundational step-by-step process to achieving decarbonization goals.
Streamlining Decarbonization: Key Strategies and Net-Zero Planning begins by laying the groundwork for a fundamental understanding of concepts surrounding greenhouse gas (GHG) emission reduction. This opening section discussed technical terminology, corporate drivers of the rise of decarbonization, and recent changes to the regulatory environment. The November 16 seminar's highlight was a step-by-step breakdown of the decarbonization strategy process, from emission source identification to short- and long-term change management framework design and planning.
The event is the latest in a series of emissions-focused corporate educational materials that ADEC ESG Solutions has released, including articles on the basics of decarbonization and the role of supply chain engagement in scope 3 GHG emissions management, as well as an in-depth white paper focused on carbon accounting methods. These complementary resources are a key part of ADEC ESG's resource library, catered to organizations looking to make impactful changes to their overall strategy and demonstrate a strong commitment to environmental, social, and governance (ESG) goals.
ADEC ESG Solutions has helped private and public organizations as well as municipalities at every step on their Sustainability Journey, from strategy development, data collection, analysis, and planning, through implementation, tracking and automation, and reporting. "The market has shifted beyond just disclosure, and customers are asking to not only see commitments but to see a decarbonization path or net-zero plans," said ADEC ESG Solutions Head of ESG Strategy and Implementation, Culley Thomas, emphasizing market, regulatory, and internal pressure on organizations to demonstrate real progress on ESG goals.
A recording of Streamlining Decarbonization: Key Strategies and Net-Zero Planning, including the real-time Q&A session, as well as ADEC ESG Solutions' library of resources for decarbonization and overall sustainability and resiliency strategies, can be found at https://www.adecesg.com/resources/.
About ADEC Innovations
ADEC Innovations' ESG business advances sustainable practices around the world and helps organizations responsibly grow and operate. With a global workforce spanning six continents, ADEC ESG Solutions seamlessly delivers fully-integrated, cost-effective consulting, data management, and software solutions to ensure we meet our clients' ever-evolving ESG needs. Visit adecesg.com to learn more.
SAN FRANCISCO - November 22, 2022 - (Newswire.com)
Arterys, developer of the world's first internet platform for medical imaging, now part of Tempus, announced its organic growth of products and partnerships to serve radiologists with even faster and more accurate diagnostic tools.
"Arterys is at a pivotal point in time in which we are really uniquely positioned to scale our solutions," said Arterys CEO John Axerio-Cilies. "We're excited to introduce new partnerships and product updates that will support physicians in delivering personalized, data-driven patient care."
Arterys Breast AI gains traction concluding Breast Cancer Awareness Month
Arterys' Breast AI product has seen rapid expansion, with several new customers recently adopting the cloud-based solution and many more committed to 2023.
Three recent technology adopters chose Arterys for different reasons:
In Salina, Kansas, Arterys Breast AI's SaaS model allowed the site to implement advanced technology with an operational budget.
In Florida, a national breast company was excited by the breast triage worklist combined with the CAD case score results, helping to direct patients to advanced diagnostic imaging immediately — they will expand the solution over multiple sites nationwide over the next year
A third site in Montana found that Arterys was agnostic to multiple gantry vendors and that the cloud solution could be added to the new gantry and deployed to older ones without capital equipment.
Arterys enhances ecosystem with new strategic partnerships
InferVision — Arterys and InferVision have partnered to offer an optimized AI-driven lung oncology workflow with FDA-cleared detection, segmentation, and follow-up. Using the partnership's automated selection of nodule types and automated Lung-rads scoring and RECIST increases reporting efficiency.
DeepLook Medical — Arterys and DeepLook Medical have joined forces to offer physicians efficiency and remove subjectivity from their oncology workflow. DeepLook's FDA-cleared DL Precise™ automated segmentation tool has been added to the Arterys radiology platform. Precise measurements are crucial to accurately characterize tumors for cancer treatment plans, as well as to assess the tumor's growth rate over time or tumor shrinkage in response to therapy. This partnership created a one-click tool to automate the segmentation and measurement of suspicious objects in all imaging modalities, moving one step closer to delivering on a vision of precision medicine and personalized patient care.
Amazon Web Services (AWS) — Arterys is working with AWS, related to the recently announced Amazon HealthLake Imaging, a new HIPAA-eligible capability for storing, sharing, and analyzing medical images at petabyte scale, now available in preview. As an AWS Partner, Arterys is leveraging HealthLake Imaging to enhance performance and responsiveness across its applications, such as Lung AI, which helps physicians analyze and track lung nodules. Arterys will demonstrate the use of HealthLake Imaging in the AWS booth (#6958) during RSNA.
HealthLake Imaging enables access to medical imaging data with sub-second image retrieval latencies at scale powered by cloud-native APIs and applications from AWS Partners. Providers eliminate the burden of infrastructure management and enable AI/ML to drive increased value from imaging data with support from other services. This allows providers to focus resources on meeting the growing demands of clinical workflows and delivering high-quality patient care.
Arterys has been recently acquired by Tempus, a technology company advancing precision medicine through the practical application of AI. Launched in 2015, the company's platform helps enable physicians to make near real-time, data-driven decisions to deliver personalized patient care and, in parallel, facilitates discovery, development, and delivery of optimal therapeutics to enable doctors to make data-driven treatment decisions, drug companies to make better drugs, and patients to live longer and healthier lives. Together, the two companies aim to better support physicians by providing the AI-enabled solutions necessary to optimize care.
To learn more about Arterys, visit www.arterys.com or meet them at Booth #4719 at RSNA 2022 in Chicago, Nov. 27-30, 2022.
About Arterys
Arterys, now a part of Tempus, received the first-ever FDA Clearance of a DL/AI Model (Arterys Cardiac AI Model) and was the first developer of an internet platform for medical imaging. Driven by a vision to create a world where clinical care is data-driven and intelligent, Arterys provides fast, accurate, and actionable medical imaging insights that empower physicians to make more informed treatment decisions and deliver better patient care. With a single and seamless integration, Arterys offers radiology departments a dedicated medical imaging platform with a comprehensive set of clinical AI workflow solutions — adding value across a wide range of specialties. Arterys' medical imaging platform, with industry-leading FDA-cleared medical imaging applications and AI, delivers customers a high return on investment, combined with a low cost to implement and manage. For more information on Arterys, please visit www.arterys.com.
About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of clinical and molecular data and an operating system to make that data accessible and useful, Tempus enables physicians to make near real-time, data-driven decisions to deliver personalized patient care and, in parallel, facilitates discovery, development, and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit www.tempus.com.
About InferVision
InferVision is a leading, global high-tech enterprise in medical artificial intelligence. Aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, treatment outcomes, and lower cost, InferVision is using AI and deep learning technologies to develop multiple platforms, including an AI applications management platform, an AI data-mining research platform, and several AI clinical application platforms, as well as medical A.I. systems for quality control, health management, and scientific research. InferVision provides advanced, intelligent, and systematic services to payors, providers, and patients realizing "Advancing Technology, Inspiring Healthcare." For more information: https://us.infervision.com.
About DeepLook Medical
DeepLook Medical, Inc., a medical imaging software company, has pioneered shape-search technology to create tools that streamline radiologist workflow, ensure precision and scalability, improve patient care, and generate cost savings. DL Precise is FDA-cleared software that ensures instantaneous, consistent lesion segmentation and measurement in multiple imaging modalities — all with a single mouse click. It is a versatile utility, easily deployed across the treatment pathway — from image acquisition, through screening and diagnostic imaging, to monitoring and treatment. For more information, please visit www.deeplookmedical.com.
Contact Information:
Mollie Schane
Head of Marketing [email protected]
(650) 319-7230
WEST PALM BEACH, Fla./GUJARAT, India - November 22, 2022 - (Newswire.com)
USPA Global Licensing Inc. (USPAGL) and Arvind Fashions Limited today announced that U.S. Polo Assn., the official brand of the United States Polo Association (USPA), has been awarded the "Best Men's Casualwear Brand" for the third consecutive year and "Best Casual Footwear Brand" for the second time at the Myntra Tech Thread Awards 2022. The multi-billion-dollar, sport-inspired global brand won the highly contested awards over other leading, global brands.
Myntra is the most recognized e-commerce fashion platform in India, selling a wide range of products from categories like apparel, beauty, footwear, bags and more. Myntra Tech Thread Awards recognizes the dynamic shift in the current business world and the necessity of companies having to re-think experiences, build stronger partnerships and adapt to disruptions in the market.
"We would like to thank Myntra, its team, and all of our loyal customers on the Myntra platform for the honor given to Arvind and U.S. Polo Assn.," said Amitabh Suri, CEO, Arvind Fashions Limited's U.S. Polo Assn. India. "Myntra and U.S. Polo Assn. go back a long way. What began as a business engagement many years back has today transcended into a champion partnership, due to a shared passion for the business, innovation and a customer-obsessed culture."
Today, U.S. Polo Assn. has reached $1.8 billion in global retail sales, achieved double-digit growth, and expanded its footprint to include 190 countries and more than 1,200 U.S. Polo Assn. retail stores worldwide, more than 400 of them being in India.
J. Michael Prince, President and CEO of USPA Global Licensing, who oversees the overall multi-billion-dollar world-class U.S. Polo Assn. brand, added, "Arvind Fashions Limited is a partner who understands the sport-inspired DNA of the U.S. Polo Assn. brand. I thank the Arvind team for their outstanding contributions as global partners and for playing a major role in U.S. Polo Assn.'s global success."
Myntra Tech Thread Awards brings together more than 250 leading domestic and global fashion brands to celebrate the business of fashion. This year focused on the future of fashion ranging from technology and social commerce, evolving consumer behavior and the transformation of fashion retail in India in today's global market.
About U.S. Polo Assn. and USPA Global Licensing Inc. (USPAGL)
U.S. Polo Assn. is the official brand of the United States Polo Association (USPA), the nonprofit governing body for the sport of polo in the United States and one of the oldest sports governing bodies, having been founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through some 1,200 U.S. Polo Assn. retail stores and thousands of department stores as well as sporting goods channels, independent retailers and e-commerce, U.S. Polo Assn. offers apparel for men, women, and children, as well as accessories and footwear in 190 countries worldwide. Today, U.S. Polo Assn. is ranked the 28th largest licensor in the world and within the top five sports licensors, according to License Global's 2022 list of "Top Global Licensors." Visit uspoloassnglobal.com.
USPA Global Licensing Inc. (USPAGL) is the for-profit subsidiary of the USPA and its exclusive worldwide licensor. USPAGL manages the global, multi-billion-dollar U.S. Polo Assn. brand and is the steward of the USPA's intellectual properties, providing the sport with a long-term source of revenue. Through its subsidiary, Global Polo Entertainment (GPE), USPAGL also manages Global Polo TV, the world's leading digital platform with polo and lifestyle content. In addition, USPAGL partners with ESPN and beIN Sports globally to share the sport of polo broadcasts on television and on-demand to millions of viewers around the world. For more polo content visit globalpolo.com.
About Arvind Fashions Limited
Arvind Fashions Limited is India's number one casual and denim brand, a lifestyle powerhouse with a strong portfolio of fashion brands catering to consumers across many sub-categories and price points. With a host of renowned brands, both indigenous and international, like U.S. Polo Assn., ARROW, Calvin Klein, Flying Machine and Sephora, the global industry leader has a presence across lifestyle brands, value fashion and prestige beauty. Visit arvindfashions.com.
WEST PALM BEACH, Fla./GUJARAT, India - November 22, 2022 - (Newswire.com)
USPA Global Licensing Inc. (USPAGL) and Arvind Fashions Limited today announced that U.S. Polo Assn., the official brand of the United States Polo Association (USPA), has been awarded the "Best Men's Casualwear Brand" for the third consecutive year and "Best Casual Footwear Brand" for the second time at the Myntra Tech Thread Awards 2022. The multi-billion-dollar, sport-inspired global brand won the highly contested awards over other leading, global brands.
Myntra is the most recognized e-commerce fashion platform in India, selling a wide range of products from categories like apparel, beauty, footwear, bags and more. Myntra Tech Thread Awards recognizes the dynamic shift in the current business world and the necessity of companies having to re-think experiences, build stronger partnerships and adapt to disruptions in the market.
"We would like to thank Myntra, its team, and all of our loyal customers on the Myntra platform for the honor given to Arvind and U.S. Polo Assn.," said Amitabh Suri, CEO, Arvind Fashions Limited's U.S. Polo Assn. India. "Myntra and U.S. Polo Assn. go back a long way. What began as a business engagement many years back has today transcended into a champion partnership, due to a shared passion for the business, innovation and a customer-obsessed culture."
Today, U.S. Polo Assn. has reached $1.8 billion in global retail sales, achieved double-digit growth, and expanded its footprint to include 190 countries and more than 1,200 U.S. Polo Assn. retail stores worldwide, more than 400 of them being in India.
J. Michael Prince, President and CEO of USPA Global Licensing, who oversees the overall multi-billion-dollar world-class U.S. Polo Assn. brand, added, "Arvind Fashions Limited is a partner who understands the sport-inspired DNA of the U.S. Polo Assn. brand. I thank the Arvind team for their outstanding contributions as global partners and for playing a major role in U.S. Polo Assn.'s global success."
Myntra Tech Thread Awards brings together more than 250 leading domestic and global fashion brands to celebrate the business of fashion. This year focused on the future of fashion ranging from technology and social commerce, evolving consumer behavior and the transformation of fashion retail in India in today's global market.
About U.S. Polo Assn. and USPA Global Licensing Inc. (USPAGL)
U.S. Polo Assn. is the official brand of the United States Polo Association (USPA), the nonprofit governing body for the sport of polo in the United States and one of the oldest sports governing bodies, having been founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through some 1,200 U.S. Polo Assn. retail stores and thousands of department stores as well as sporting goods channels, independent retailers and e-commerce, U.S. Polo Assn. offers apparel for men, women, and children, as well as accessories and footwear in 190 countries worldwide. Today, U.S. Polo Assn. is ranked the 28th largest licensor in the world and within the top five sports licensors, according to License Global's 2022 list of "Top Global Licensors." Visit uspoloassnglobal.com.
USPA Global Licensing Inc. (USPAGL) is the for-profit subsidiary of the USPA and its exclusive worldwide licensor. USPAGL manages the global, multi-billion-dollar U.S. Polo Assn. brand and is the steward of the USPA's intellectual properties, providing the sport with a long-term source of revenue. Through its subsidiary, Global Polo Entertainment (GPE), USPAGL also manages Global Polo TV, the world's leading digital platform with polo and lifestyle content. In addition, USPAGL partners with ESPN and beIN Sports globally to share the sport of polo broadcasts on television and on-demand to millions of viewers around the world. For more polo content visit globalpolo.com.
About Arvind Fashions Limited
Arvind Fashions Limited is India's number one casual and denim brand, a lifestyle powerhouse with a strong portfolio of fashion brands catering to consumers across many sub-categories and price points. With a host of renowned brands, both indigenous and international, like U.S. Polo Assn., ARROW, Calvin Klein, Flying Machine and Sephora, the global industry leader has a presence across lifestyle brands, value fashion and prestige beauty. Visit arvindfashions.com.
Next-generation proteomics technology made available to the biotech and pharmaceutical industry through the acquisition of Methuselah Health by leading R&D services provider, RxCelerate
CAMBRIDGE, England - November 22, 2022 - (Newswire.com)
RxCelerate, a leading international out-sourced drug discovery and development platform, today announced the acquisition of drug discovery company Methuselah Health UK Ltd for an undisclosed sum. Methuselah Health was founded in 2015 to discover drugs for age-related diseases driven by proteomic instability and has developed the world's most powerful proteomics platform to power its discovery efforts.
"Until now, the ProQuant™ proteomics technology has only been available for the internal discovery programs at Methuselah Health," said Jill Reckless, CEO at RxCelerate. "But as soon as we saw just how powerful this technology was, we had to add it to our service offering. Through this acquisition, the proprietary ProQuant™ platform will be exclusively available to our clients, giving them access to the best proteomics technology available anywhere."
The development of ProQuant™ was led by David Mosedale, Chief Technical Officer at Methuselah Health since its foundation in 2015. "Proteomics has been an important tool in drug discovery for decades, but existing methods typically focus on the number of proteins identified at the expense of quantitative accuracy. ProQuant™ is a step-change in quantitative accuracy for bottom-up LC-MS-MS-based proteomics, which enables a whole range of applications that are difficult or impossible with existing technology. For example, ProQuant™ can better quantify post-translational modifications, including proteolytic cleavages, in complex protein mixtures, which opens up a new domain for target identification and validation, biomarker discovery and reaction monitoring."
ProQuant™ moves the goalposts for proteomics through proprietary improvements in both the analytical and bioinformatic domains. "The key development," says Mosedale, "was identifying a way to assess quantitative accuracy across the whole proteome simultaneously, even without knowing the true concentration of any of the components. That allowed us to optimize the methodology beyond anything that has been possible before."
ProQuant™ has numerous applications across the drug discovery and development domains. It turbo-charges chemoproteomics during discovery of covalent binders (including protacs), allows the accumulation of post-translational modifications on biologic drugs to be accurately monitored during manufacture, storage and, most importantly, after administration in vivo, and delivers accurate quantitation of protein labelling.
"Unfortunately, many drug developers do not realise the extent to which the poor quantitative accuracy of traditional proteomics has limited its usefulness. ProQuant™ really is a game-changer," explains Mosedale.
"Over the last several years, we have acquired or developed a unique toolkit of cutting-edge technologies to improve drug discovery and development," said Nick Tait, Chief Financial Officer at RxCelerate. "Galaxy™, our platform to discover better monoclonal antibody drugs at RxBiologics, and RxNfinity™, our dynamic chemical space to improve small molecule discovery, deliver best-in-class capabilities to our clients. With the acquisition of Methuselah Health and its ProQuant™ proteomics technology, we have taken another step towards our vision of making the best technologies out there available to everyone."
Notes for Editors
About RxCelerate
RxCelerate is an out-sourced drug discovery and development company, founded in Cambridge, UK, in 2013, with a focus on working smarter. It has grown rapidly to become one of the leading providers of drug development services in the United Kingdom. RxCelerate operates a unique model, providing capabilities to discover and develop drugs for clients, designing as well as executing every aspect of the research and development plan.
RxCelerate offers a wide range of services. The biology team specializes in in vivo pharmacology, offering proprietary models of wide range of human diseases, as well as complex cell-based assays. The chemistry team provides medicinal chemistry, including in silico screening and the RxNfinity™ dynamic chemical space, as well as synthesis that integrates seamlessly with the in vitro testing capability. A dedicated team designs the optimum discovery or development strategy for each project, as well as integrated program management. By working closely together, these teams can deliver pharma-grade drug product candidates at a fraction of the cost of traditional approaches.
RxCelerate has a team of more than 80 employees and consultants based in 25,000 square feet of premium laboratory and office space in the Dorothy Hodgkin Building at the Babraham Research Campus, approximately five miles south of Cambridge, UK, as well as offices in Boston, MA, and San Francisco, CA.
For more information, please visit us at rxcelerate.com and connect with us on Twitter (@RxCelerate). Contact our UK headquarters: [email protected] Tel: +44 (0)1223 804240. Contact our US headquarters: [email protected] Tel: +1 (857) 409-6028
Contact Information:
Jill Reckless
CEO [email protected]
+44 1223 804240
E Woman is shifting its business model to offer critical aid to single mothers with special needs children.
NASHVILLE, Tenn. - November 22, 2022 - (Newswire.com)
E Woman, a social networking platform for women, is pleased to announce its transition to a nonprofit organization to provide critical aid to single mothers who have special needs children. This initiative will start in Uzbekistan, with the goal of expanding globally. While the company will remain a social networking platform as well, it is now expanding its reach so its ability to offer support can be taken to the next level.
In Uzbekistan, women still have limited opportunities to control their own futures due to societal restrictions. In addition, with some having special-needs children, many women are abandoned by their partners and left to fend for themselves. For Amy Shakhlo Karaman, founder and CEO of E Woman and a native of the country, this cause matters deeply.
"As a woman who has experienced the traditions in Uzbekistan first-hand, I recognize it's not always easy to establish your independence given these incredibly difficult circumstances," said Karaman. "At E Woman, we aim to support women in all aspects of their lives and look forward to the opportunity to offer additional aid through our new status as a nonprofit organization."
As E Woman shifts to a nonprofit, it has several upcoming initiatives that aim to provide assistance:
Through its Bright Soul Bracelets program, E Woman is able to travel to Uzbekistan and provide jobs to women by teaching them how to make bracelets. These bracelets are then sold in the U.S., and all profits raised go to single mothers.
In Uzbekistan, E Woman has partnered with the Committee on Women and Gender Equality and the Commission on Ensuring Gender Equality from the Senate of the Oliy Majlis, which is the parliament of the country.
Through the above partnership, E Woman has a goal to build at least five safe houses. The Gender Equality Commission is looking into ways to provide the necessary land to accomplish this mission.
E Woman also plans to serve women facing gender discrimination in Iran and Afghanistan.
In Tennessee, E Woman is working to have 10 female artists from Central Asia come to the U.S. to have a chance to showcase their artwork in a display called The Inside World of Central Asian Women.
The E Woman app was created to serve as an online women's support group and give women a safe place to empathize with others who may be going through similar experiences. It also provides forums for different events and stages in a woman's life, including single moms, working moms, finding work-life balance and coping with a loss.
E Woman is available on www.ewoman.world and offered in every language. Members can join categorized groups anonymously or with their usernames to share their stories and connect in a judgment-free space.
E Woman is a social media platform dedicated to every woman who feels alone. Founded by Amy Shakhlo Karaman, an immigrant who escaped an arranged marriage in Uzbekistan and came to America to build her life from the ground up, this online community allows women around the world to discuss similar struggles. E Woman is now available on www.ewoman.world and offers every language. Members can join categorized groups anonymously or with their usernames to share their stories and connect in a judgment-free space. To learn more, visit www.ewoman.world.
The Limited Art Collection is an alliance between two true icons, a bespoke Coachbuilder from Italy, ARES Modena and 'The perfect gin'; No.3 Gin. The collaboration will be brought to life by Artist, Daniela Boo, at Basel 2022, showcasing the precise balance of uniqueness.
No.3 Gin, created by renowned London wine and spirit merchants Berry Bros. & Rudd, is pleased to announce a truly iconic collaboration with ARES Modena, Luxury Italian coachbuilder and Daniela Boo, Argentine artist at Art Basel 2022.
At the exclusive event on Nov. 28 at Art Basel 2022, Daniela Boo will paint front elements of the ARES S1 Coupe model (currently located in the ARES Modena studio in the Miami Design District), whilst a master mixologist will be on hand serving special drinks made with No.3 Gin throughout the night.
Daniela Boo, represented by BlackTower Gallery, has a history of painting iconic supercars, and has previously been selected by various automotive brands for unique artistic expressions, her creative work combining hyper realism and speed. A number of these aesthetic vehicles are on display in museums and private collections globally. Now it's Miami's turn to witness Daniela Boo's profound artistic abilities for the first time.
Since 2010, No.3 Gin has been the winner of the World's Best Gin four times and the first gin to win the Supreme Champion Spirit at the International Spirits Challenge naming it The Perfect Gin, featuring a special recipe of six botanicals created by the celebrated Berry Bros & Rudd. The collaborative event has been designed to feed into Miami's thirst to explore and discover the parallels between art and modern expression.
Commenting on the collaboration, Edrington's No.3 Gin said: 'We can't wait to host this fabulous event at Basel 22. ARES Modena's commitment to legacy and their never-ending pursuit to evolve their craft, makes ARES the perfect match to collaborate with No.3 Gin. The collaborations combine the artistic and modern expressions in a way that celebrates uniqueness and where better to unveil this stunning collection than Miami.'
Mo Elarishy, Head of Business Development at ARES Miami, said: 'The shape of a vehicle provides an artist a unique canvas to express their passion and vision. The combination of curves on the exterior body with art can create an emotional influence and arouse desire, it is all about having a meaningful aesthetic feel. Collaborating during Art Basel Miami was the perfect time to showcase Daniela Boo's artwork.'
For more information on London No.3 Gin and the Artist Collaboration event, please visit https://no3gin.com
The partnership will bring virtual cardiac rehabilitation and recovery into the homes of patients in Davis Health System's service area.
NEW YORK & ELKINS, W.V. - November 22, 2022 - (Newswire.com)
Recora today announced it has been selected by Davis Health System for its Virtual Cardiac Recovery Program. This program will deliver cardiac rehabilitation in a way that has never been available to the region before, creating new opportunities for patients to recover and transform their lives from the comfort of their homes.
"Our team is dedicated to improving the cardiac rehabilitation process for our patients. We know how valuable this program is to improving their health and extending their life, but the biggest challenge continues to be patients showing up and sticking with the program," said Kathy Sturm, VP & Chief Nursing Officer, Davis Health System. "With Recora expanding our cardiac rehab program to a virtual environment, we believe this will increase patient participation and eliminate many of the challenges that have prevented patients from engaging, or even being able to participate, especially in the rural community we serve. Given the assistance and coach provided to each patient enrolled in this virtual program, Recora is set up to help patients overcome technical concerns as well."
Through virtual tools provided to patients and on-demand access to care teams and other resources, the program empowers patients to manage their heart health from home while enabling providers and plans to provide comprehensive cardiac care and strengthen patient relationships. Recora's Cardiac Recovery Program moves beyond 12 weeks of rehabilitation to deliver comprehensive care management that focuses on a patient's overall health and wellness.
Recora currently serves cardiac patients in the U.S. across health systems, health plans and medical groups in urban, suburban and rural communities.
"Davis Health System has taken a critical step forward serving their community in cardiac rehab, and we are proud to partner with them in these efforts," said Recora CEO Abhishek Chandra. "Currently only about 1 in 4 eligible patients ever start a center-based program. The addition of a virtual program with an outreach strategy has been shown to engage more patients overall, including a 15% increase in center-based patients."
15% hospital readmission rate for Recora patients, versus the national average of 43% across Medicare patients with heart failure at six months.
87% Recora cardiac recovery program completion rate, versus the national average of 26%.
80% of patients with hypertension markedly improved their blood pressure due to diet and exercise
94% of Recora patients adhere to their cardiac medication.
80% improvement of distance and strength gains among Recora patients.
ABOUT RECORA
Recora's mission is to redefine the future of heart health. Recora's Cardiac Recovery Program for health systems, medical groups and health plans makes it easier to recover from a cardiac event through immersive programs delivered online. With Recora, healthcare providers are able to establish a longitudinal relationship with patients and help them live longer, fuller lives. To learn more, visit recora.com.
ABOUT DAVIS HEALTH SYSTEM
At Davis Health System we have the technology, expertise and services that make us the regional choice for prevention, detection and treatment of disease. As rare as that level of medical advancement is in a rural community, it's CARE that defines us.
Healthcare is people taking care of people. Here, our employees care for families, loved ones, friends, neighbors, visitors… and every person counts; every person benefits from safe and excellent care.
Davis Medical Center (DMC) has been identified as one of the Top 20 Rural Community Hospitals in the nation. According to NRHA, Davis Medical Center outperformed numerous rural hospitals nationwide in an evaluation done by the Chartis Center for Rural Health using iVantage Health Analytics. Hospitals were analyzed in eight areas: inpatient market share, outpatient market share, quality, outcomes, patient perspective, cost, charge and financial stability.
Contact Information:
Adam Hritzak
Director of Marketing, Recora [email protected]
614-946-7916
Tracy Fath
VP, Marketing, Davis Health System [email protected]
(304) 637-3467
